Henry Schein, Inc.
A global distributor supplying office-based dentists and doctors with everything from dental implants and biomaterials to practice-management software and everyday supplies. It grew out of a single New York City pharmacy that founder Henry Schein and his wife Esther opened in 1932 during the Great Depression, later shifting to mail-order medical supplies. In those hard years, Henry kept a notebook behind the counter listing customers who couldn't pay, letting them take medicine on trust—a habit of service that shaped the company's culture.
Granted 393.2K · Sold 264.0K
Granted 61.8K · Sold 44.9K
Granted 19.9K
Granted 81.8K
Granted 123.1K · Sold 48.2K
Granted 128.9K · Sold 64.0K
Granted 7.5K · Sold 11.5K
Granted 95.2K
Granted 78.8K
Granted 67.5K · Sold 1.4K
Granted 36.0K · Sold 36.4K
Granted 30.6K · Sold 11.2K
Granted 55.4K · Sold 28.5K
Granted 2.0K
Granted 12.3K · Sold 11.2K
Granted 41.4K · Sold 29.7K
Granted 9.7K
Granted 12.3K
Granted 7.6K · Bought 20.0K
Granted 12.3K · Sold 18.9K
Granted 12.3K
Granted 2.0K
Granted 7.1K
Granted 12.3K
Granted 12.3K · Sold 11.3K
Granted 12.3K
Granted 12.3K
Granted 12.3K · Bought 1.0K
Granted 8.0K
Granted 5.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Bergman Stanley MFormer Director · 90 transactions | -28.7% | 1.31M | 393.2K | — | 264.0K |
| Breslawski James PPresident · 21 transactions | -16.8% | 200.2Kas of Mar 2025 | 61.8K | — | 44.9K |
| Paladino StevenDirector · 15 transactions | -4.2% | 144.9Kas of Mar 2024 | 19.9K | — | — |
| Albertini AndreaCEO, Global Dist. & Tech. · 8 transactions | — | 120.7K | 81.8K | — | — |
| Ettinger Michael SEVP & Chief Operating Officer · 34 transactions | +23.2% | 112.4K | 123.1K | — | 48.2K |
| Mlotek Mark EEVP, Chief Strategic Officer · 33 transactions | — | 109.9K | 128.9K | — | 64.0K |
| Benjamin Gerald AEVP, Chief Admin. Officer · 6 transactions | -15.8% | 101.4Kas of May 2022 | 7.5K | — | 11.5K |
| Lowery Frederick M.CEO, Director · 2 transactions | — | 95.2K | 95.2K | — | — |
| South Ronald N.SVP & Chief Financial Officer · 14 transactions | — | 88.9K | 78.8K | — | — |
| Popeck Thomas CCEO, Henry Schein Products · 8 transactions | — | 86.2K | 67.5K | — | 1.4K |
| McGlynn LoreleiSVP, Chief Human Res. Officer · 14 transactions | +117.2% | 72.3Kas of Sep 2024 | 36.0K | — | 36.4K |
| Brous David B JrCEO, Strategic Business Group · 11 transactions | — | 69.7Kas of Jun 2023 | 30.6K | — | 11.2K |
| Connett Bradford CCEO, NA Distribution Group · 19 transactions | — | 62.7Kas of Mar 2025 | 55.4K | — | 28.5K |
| Alperin Barry JDirector · 2 transactions | +2.8% | 52.5Kas of Mar 2022 | 2.0K | — | — |
| Sheares Bradley TDirector · 10 transactions | -3.4% | 47.6K | 12.3K | — | 11.2K |
| Siegel WalterSr. VP & Chief Legal Officer · 19 transactions | -14.5% | 43.2Kas of Mar 2025 | 41.4K | — | 29.7K |
| Raphael CarolDirector · 8 transactions | +28.7% | 33.5Kas of May 2025 | 9.7K | — | — |
| Herring Joseph LDirector · 5 transactions | +68.3% | 30.3K | 12.3K | — | — |
| Daniel William KDirector · 5 transactions | — | 27.6K | 7.6K | 20.0K | — |
| Laskawy Philip ADirector · 10 transactions | -21.2% | 24.5K | 12.3K | — | 18.9K |
| Margulies Anne H.Director · 10 transactions | +66.6% | 23.2K | 12.3K | — | — |
| Rekow E DianneDirector · 2 transactions | +8.3% | 18.5Kas of Mar 2022 | 2.0K | — | — |
| Sheehy Christine ZayacSVP, Chief Human Res. Officer · 4 transactions | — | 18.5K | 7.1K | — | — |
| Derby DeborahDirector · 5 transactions | +346.6% | 15.9K | 12.3K | — | — |
| Kuehn Kurt PDirector · 13 transactions | -3.3% | 15.4K | 12.3K | — | 11.3K |
| Ali MohamadDirector · 7 transactions | +297.8% | 15.1K | 12.3K | — | — |
| Tuckson Reed VaughnDirector · 9 transactions | +464.7% | 12.5K | 12.3K | — | — |
| Serota Scott PhilipDirector · 9 transactions | — | 11.8K | 12.3K | 1.0K | — |
| Faig Carole TDirector · 3 transactions | — | 8.0K | 8.0K | — | — |
| Hombach Robert J.Director · 2 transactions | — | 5.4K | 5.4K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 5 years: -560.3K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.